Complexes Of Il-15 And Il-15R Alpha And Uses Thereof - EP2724728

The patent EP2724728 was granted to Admune Therapeutics on Oct 17, 2018. The application was originally filed on Jun 27, 2008 under application number EP13195499A. The patent is currently recorded with a legal status of "Revoked".

EP2724728

ADMUNE THERAPEUTICS
Application Number
EP13195499A
Filing Date
Jun 27, 2008
Status
Revoked
Mar 18, 2022
Grant Date
Oct 17, 2018
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status

Get instant alerts for new oppositions and patent status changes

HGFJul 16, 2019-ADMISSIBLE

Patent Citations (56) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication NumberPublication Link
DESCRIPTIONUS20060758819-
DESCRIPTIONUS20060812566-
DESCRIPTIONEP0219878
DESCRIPTIONGB2034323
DESCRIPTIONUS2001055807
DESCRIPTIONUS2002098189
DESCRIPTIONUS2004028685
DESCRIPTIONUS2004220140
DESCRIPTIONUS2005019330
DESCRIPTIONUS2005048549
DESCRIPTIONUS2007086943
DESCRIPTIONUS4675187
DESCRIPTIONUS4705540
DESCRIPTIONUS4717393
DESCRIPTIONUS4717394
DESCRIPTIONUS4838900
DESCRIPTIONUS4851505
DESCRIPTIONUS4863496
DESCRIPTIONUS4880442
DESCRIPTIONUS4889803
DESCRIPTIONUS4912197
DESCRIPTIONUS4935490
DESCRIPTIONUS4961539
DESCRIPTIONUS5622834
DESCRIPTIONUS5623064
DESCRIPTIONUS5624679
DESCRIPTIONUS5686115
DESCRIPTIONUS5807715
DESCRIPTIONUS5858350
DESCRIPTIONUS5965726
DESCRIPTIONUS6162432
DESCRIPTIONUS6174666
DESCRIPTIONUS6291664
DESCRIPTIONUS6331415
DESCRIPTIONUS6414132
DESCRIPTIONUS6599720
DESCRIPTIONUS6686342
DESCRIPTIONUS6794498
DESCRIPTIONUS6818216
DESCRIPTIONUS7115588
DESCRIPTIONWO0168882
DESCRIPTIONWO02069904
DESCRIPTIONWO02098370
DESCRIPTIONWO0246237
DESCRIPTIONWO2005085282
DESCRIPTIONWO2007070488
DESCRIPTIONWO2007084342
DESCRIPTIONWO9308656
DESCRIPTIONWO9412650
DESCRIPTIONWO9418318
DESCRIPTIONWO9530695
OPPOSITIONUS2006263857
OPPOSITIONWO2007046006
OPPOSITIONWO2007084342
SEARCHUS2006165668
SEARCHWO2007084342

Non-Patent Literature (NPL) Citations (205) New

NPL citations refer to non-patent references such as research papers, articles, or other publications cited during examination or opposition phases.

Citation PhaseReference TextLink
DESCRIPTION- ADAMES ET AL., NATURE, (1985), vol. 318, pages 533 - 538-
DESCRIPTION- AHMAD ET AL., AM J KIDNEY DIS, (1986), vol. 7, no. 2, pages 153 - 6-
DESCRIPTION- ALEXANDER ET AL., MOL. CELL. BIOL., (1987), vol. 7, pages 1436 - 1444-
DESCRIPTION- ALEXANDRAKIS ET AL., BR J OPHTHALMOL., (1998), vol. 82, no. 3, pages 306 - 11-
DESCRIPTION- ALTMAN ET AL., SCIENCE, (1996), vol. 274, pages 94 - 96-
DESCRIPTION- ALTURE-WERBER E; EDBERG SC, MYCOPATHOLOGIA, (1985), vol. 89, no. 2, pages 69 - 73-
DESCRIPTION- ANDRUTIS ET AL., J CLIN MICROBIOL., (2000), vol. 38, no. 6, pages 2317 - 23-
DESCRIPTION- ARATANI ET AL., MED MYCOL, (2002), vol. 40, no. 6, pages 557 - 563-
DESCRIPTION- ARENDRUP ET AL., INFECTION, (2002), vol. 30, no. 5, pages 286 - 91-
DESCRIPTION- ARICO ET AL., J INTERFERON CYTOKINE RES, (2002), vol. 22, no. 11, pages 1081 - 8-
DESCRIPTION- AYASH-RASHKOVSKY ET AL., FASEB J., (2005), vol. 19, pages 1149 - 1151-
DESCRIPTION- BALASUBRAMANIAN ET AL., IMMUNOBIOLOGY, (1994), vol. 191, no. 4-5, pages 395 - 401-
DESCRIPTION- BARBEE ET AL., AM J PATHOL., (1977), vol. 86, no. 1, pages 281 - 4-
DESCRIPTION- BEERS ET AL., J LAB CLIN MED., (1999), vol. 133, no. 5, pages 423 - 33-
DESCRIPTION- BEMOIST; CHAMBON, NATURE, (1981), vol. 290, pages 304 - 310-
DESCRIPTION- Biocbemica, ROCHE MOLECULAR BIOCHEMICALS, (1999), page 34 37-
DESCRIPTION- Biochemica, ROCHE MOLECULAR BIOCHEMICALS, (1999), page 34 37-
DESCRIPTION- BIRREN ET AL., Genome Analysis: A Laboratory Manual, COLD SPRING HARBOR PRESS, (1997), vol. 1-4--
DESCRIPTION- BOLGER ET AL., ANTIVIRAL RES., (1997), vol. 35, pages 157 - 165-
DESCRIPTION- BONYHADI ET AL., MOL. MED. TODAY, (1997), vol. 3, pages 246 - 253-
DESCRIPTION- BOURNE ET AL., ANTIVIRAL RES., (2000), vol. 47, pages 103 - 109-
DESCRIPTION- BOZZA ET AL., MICROBES INFECT, (2002), vol. 4, no. 13, pages 1281 - 1290-
DESCRIPTION- BRAVO ET AL., ANTIVIRAL RES., (2003), vol. 60, pages 41 - 49-
DESCRIPTION- BRAVO ET AL., J. INFECTIOUS DISEASES, (2006), vol. 193, pages 591 - 597-
DESCRIPTION- BRIELAND ET AL., IMMUNOPHANNACOLOGY, (2000), vol. 48, no. 3, pages 249 - 52-
DESCRIPTION- BRIGHT ET AL., NATURE, (2005), vol. 436, pages 973 - 978-
DESCRIPTION- BRINSTER ET AL., NATURE, (1982), vol. 296, pages 39 - 42-
DESCRIPTION- BROWN ET AL., AM J REPROD IMMUNOL., (2001), vol. 46, no. 3, pages 232 - 41-
DESCRIPTION- BROWNING ET AL., PROC. NATL. ACAD. SCI. USA, (1997), vol. 94, pages 14637 - 14641-
DESCRIPTION- BRYANT ET AL., LAB INVEST, (2000), vol. 80, no. 4, pages 553 - 73-
DESCRIPTION- BUCHWALD ET AL., SURGERY, (1980), vol. 88, page 507-
DESCRIPTION- CACCIAPUOTI ET AL., ANTIMICROB AGENTS CHEMOTHER, (2000), vol. 44, no. 8, pages 2017 - 2022-
DESCRIPTION- CARBON ET AL., INT J BIOMED COMPUT., (1994), vol. 36, no. 1-2, pages 59 - 67-
DESCRIPTION- CAVANAUGH ET AL., J. VIROL., (1997), vol. 71, pages 3236 - 3243-
DESCRIPTION- CHAKRABARTI ET AL., J MED VET MYCOL., (1997), vol. 35, no. 4, pages 295 - 7-
DESCRIPTION- CHEN ET AL., VIROL. J, (20041123), vol. 1, page 11-
DESCRIPTION- CHU ET AL., AVIAN DIS., (1996), vol. 40, no. 3, pages 715 - 9-
DESCRIPTION- COCK ET AL., REV INST MED TROP SAO PAULO, (2000), vol. 42, no. 2, pages 59 - 66-
DESCRIPTION- COHN ET AL., J. EXP. MED., (1997), vol. 186, pages 1737 - 1747-
DESCRIPTION- COLE ET AL., FEMS MICROBIOL LETT. 15, (1995), vol. 126, no. 2, pages 177 - 80-
DESCRIPTION- CRUTE ET AL., NATURE MEDICINE, (2002), vol. 8, pages 386 - 391-
DESCRIPTION- CULLEY ET AL., J EXP MED, (2002), vol. 196, no. 10, pages 1381 - 1386-
DESCRIPTION- CURTIS ET AL., EXP BIOL MED, (2002), vol. 227, no. 9, pages 799 - 802-
DESCRIPTION- DAVIS; MATALON, NEWS PBYSIOL SCI, (2001), vol. 16, pages 185 - 90-
DESCRIPTION- DEBOER ET AL., PROC, NATL. ACAD. SCI. U.S.A., (1983), vol. 80, pages 21 - 25-
DESCRIPTION- DURING ET AL., ANN. NEUROT., (1989), vol. 25, page 351-
DESCRIPTION- EMINI, NATURE, (1983), vol. 304, page 699-
DESCRIPTION- EMSLIE; NADE, REV INFECT DIS., (1986), vol. 8, no. 6, pages 841 - 9-
DESCRIPTION- ENGLER ET AL., MOL IMMUNOL, (2001), vol. 38, no. 6, pages 457 - 65-
DESCRIPTION- EWART ET AL., J APPL PHYSIOL, (1995), vol. 79, no. 2, pages 560 - 566-
DESCRIPTION- FEHNIGER; CALIGIURI, BLOOD, (2001), vol. 97, pages 14 - 32-
DESCRIPTION- FIDEL ET AL., J INFECT DIS., (1996), vol. 173, no. 2, pages 425 - 31-
DESCRIPTION- FLANDERS ET AL., AUTOIMMUNITY, (1999), vol. 29, pages 235 - 246-
DESCRIPTION- FLANO ET AL., IMMUNOL RES, (2002), vol. 25, no. 3, pages 201 - 17-
DESCRIPTION- FODDE; SMITS, TRENDS MOL MED, (2001), vol. 7, no. 8, pages 369 - 73-
DESCRIPTION- FOSTER, SEMIN. NEPHROL., (1999), vol. 19, pages 12 - 24-
DESCRIPTION- FOWLKES ET AL., BIOTECHNIQUES, (1992), vol. 13, pages 422 - 427-
DESCRIPTION- FREIREICH ET AL., CANCER CHEMOTHER. REP., (1966), vol. 50, pages 219 - 244-
DESCRIPTION- GANEM; VARMUS, ANN. REV. BIOCHEM., (1987), vol. 56, pages 651 - 693-
DESCRIPTION- GARDNER ET AL., NUCL. ACIDS RES., (1981), vol. 9, page 2871-
DESCRIPTION- GHANEH ET AL., GENE THER, (2001), vol. 8, no. 3, pages 199 - 208-
DESCRIPTION- GILMAN ET AL., Goodman and Gilman's: The Pharmacological Basis of Therapeutics, 10th ed.,, MCGRAW-HILL-
DESCRIPTION- GOKASLAN; ANAISSIE, INFECT IMMUN., (1992), vol. 60, no. 8, pages 3339 - 44-
DESCRIPTION- GOODSON, MEDICAL APPLICATIONS OF CONTROLLED RELEASE, (1984), vol. 2, pages 115 - 138-
DESCRIPTION- GROSSCHEDL ET AL., CELL, (1984), vol. 38, pages 647 - 658-
DESCRIPTION- GRUHAD ET AL., FEMS MICROBIOL LETT, (2000), vol. 192, no. 1, pages 27 - 31-
DESCRIPTION- GUIDOTTI ET AL., J. VIROL, (1995), vol. 69, pages 6158 - 6169-
DESCRIPTION- HABERBERGER ET AL., EXPERIENTIA, (1991), vol. 47, no. 5, pages 426 - 9-
DESCRIPTION- HAMMER ET AL., SCIENCE, (1987), vol. 235, pages 53 - 58-
DESCRIPTION- HAMMERLING ET AL., Monoclonal Antibodies and T-Cell Hybridomas, ELSEVIER, (1981), pages 563 - 681-
DESCRIPTION- HAMMERLING ET AL., Monoclonal Antibodies and T-Cell Hybridomas, ELSEVIER, (1981), vol. 563, page 681-
DESCRIPTION- HANAHAN, NATURE, (1985), vol. 315, pages 115 - 122-
DESCRIPTION- HAYASHI ET AL., HISTOL HISTOPATHOL, (2002), vol. 17, no. 4, pages 1293 - 310-
DESCRIPTION- HERBER ET AL., J VIROL, (1996), vol. 70, no. 3, pages 1873 - 81-
DESCRIPTION- HERRERA-ESTRELLA ET AL., NATURE, (1984), vol. 310, pages 115 - 120-
DESCRIPTION- HERRERA-ESTRELLA ET AL., NATURE, vol. 303, pages 209 - 213-
DESCRIPTION- HONDA ET AL., MYCOPATHOLOGIA, (1998), vol. 144, no. 3, pages 141 - 146-
DESCRIPTION- HORI ET AL., EUR J IMMUNO, (2002), vol. 32, no. 5, pages 1282 - 1291-
DESCRIPTION- HOSOKAWA ET AL., TRANSGENIC RES, (2001), vol. 10, no. 5, pages 471 - 8-
DESCRIPTION- HOUGH ET AL., PROC NATL ACAD SCI USA, (1998), vol. 95, no. 23, pages 13853 - 8-
DESCRIPTION- HOWARD ET AL., J. NEUROSURG., (1989), vol. 71, page 105-
DESCRIPTION- HSIUNG ET AL., REV INFECT DIS., (1984), vol. 6, no. 1, pages 33 - 50-
DESCRIPTION- HSU ET AL., NAT. BIOTECHNOL., (2003), vol. 21, pages 519 - 525-
DESCRIPTION- ILAN ET AL., J. INFECT. DIS., (2002), vol. 185, pages 153 - 161-
DESCRIPTION- JENSEN; SCHONHEYDER, J EXP ANIM SCI., (1993), vol. 35, no. 4, pages 155 - 60-
DESCRIPTION- JOLICOEUR ET AL., LEUKEMIA, (1999), vol. 13, pages S78 - S80-
DESCRIPTION- KADO ET AL., CANCER RES, (2001), vol. 61, no. 6, pages 2395 - 8-
DESCRIPTION- KAMEI, MYCOPATHOLOGIA, (2001), vol. 152, no. 1, pages 5 - 13-
DESCRIPTION- KANE ET AL., ANTIMICROB AGENTS CHEMOTHER., (1981), vol. 20, no. 5, pages 595 - 9-
DESCRIPTION- KAZANJI, AIDS RES HUM RETROVIRUSES, (2000), vol. 16, no. 16, pages 1741 - 6-
DESCRIPTION- KELSEY ET AL., GENES AND DEVEL., (1987), vol. 1, pages 161 - 171-
DESCRIPTION- KENYON ET AL., TOXICOL APPL PHARMACOL, (2003), vol. 186, no. 2, pages 90 - 100-
DESCRIPTION- KERN ET AL., ANTIMICROB. AGENTS CHEMOTHER., (2004), vol. 48, pages 4745 - 4753-
DESCRIPTION- KLOSE, TRENDS MICROBIOL., (2000), vol. 8, no. 4, pages 189 - 91-
DESCRIPTION- KNETEMANETAL, HEPATOLOGY, (2006), vol. 43, pages 1346 - 1353-
DESCRIPTION- KOEDEL; PFISTER, INFECT DIS CLIN NORTH AM., (1999), vol. 13, no. 3, pages 549 - 77-
DESCRIPTION- KOLLIAS ET AL., CELL, (1986), vol. 46, pages 89 - 94-
DESCRIPTION- KOMAI ET AL., BR J PHARMACOL, (2003), vol. 138, no. 5, pages 912 - 920-
DESCRIPTION- KROGH, BIOCHIMIE, (1999), vol. 81, pages 511 - 515-
DESCRIPTION- KRUMLAUF ET AL., MOL. CELL. BIOL., (1985), vol. 5, pages 1639 - 1648-
DESCRIPTION- KURAGUCHI ET AL., ONCOGENE, (2000), vol. 19, no. 50, pages 5755 - 63-
DESCRIPTION- KURUP ET AL., INT ARCH ALLERGY IMMUNOL, (2002), vol. 129, no. 2, pages 129 - 137-
DESCRIPTION- KURUP ET AL., J IMMUNOL., (1992), vol. 148, no. 12, pages 3783 - 8-
DESCRIPTION- LANGER, SCIENCE, (1990), vol. 249, pages 1527 - 1533-
DESCRIPTION- LEDER ET AL., CELL, (1986), vol. 45, pages 485 - 495-
DESCRIPTION- LEE, BAILLIERES BEST PRACT RES CLIN GASTROENTEROL., (2000), vol. 14, no. 1, pages 75 - 96-
DESCRIPTION- LEVY ET AL., SCIENCE, (1985), vol. 228, page 190-
DESCRIPTION- MACDONALD, HEPATOLOGY, (1987), vol. 7, pages 425 - 515-
DESCRIPTION- MAEBASHI ET AL., J MED VET MYCOL., (1994), vol. 32, no. 5, pages 349 - 59-
DESCRIPTION- MAESTRONE ET AL., AM J VET RES., (1973), vol. 34, no. 6, pages 833 - 6-
DESCRIPTION- MARTIN ET AL., ANTIMICROB AGENTS CHEMOTHER., (1997), vol. 41, no. 1, pages 13 - 6-
DESCRIPTION- MARTINS ET AL., CRIT CARE MED, (1990), vol. 19, pages 515 - 519-
DESCRIPTION- MASON ET AL., SCIENCE, (1986), vol. 234, pages 1372 - 1378-
DESCRIPTION- MCCAULEY ET AL., ANTIVIRAL RES., (1995), vol. 27, pages 179 - 186-
DESCRIPTION- MCLANE ET AL., PROC NATL ACAD SCI OSA, (1998), vol. 19, pages 713 - 720-
DESCRIPTION- MERCER ET AL., NAT MED., (2001), vol. 7, pages 927 - 933-
DESCRIPTION- MOGRAM, NATURE, (1985), vol. 315, pages 338 - 340-
DESCRIPTION- MORRIS ET AL., J LA STATE MED SOC, (1998), vol. 150, no. 4, pages 179 - 85-
DESCRIPTION- MOSIER ET AL., Hosp. Pract (Off Ed)., (1996), vol. 31, pages 41-48 - 53-55-
DESCRIPTION- MOSIER ET AL., SEMIN. IMMUNOL., (1996), vol. 8, pages 255 - 262-
DESCRIPTION- MOSMANN, J. IIMMUNOL. METHODS, (1983), vol. 65, pages 55 - 63-
DESCRIPTION- NAJVAR ET AL., ANTIMICROB AGENTS CHEMOTHER, (1999), vol. 43, no. 2, pages 413 - 4-
DESCRIPTION- NEDRUD, FEMS IMMUNOL MED MICROBIOL., (1999), vol. 24, no. 2, pages 243 - 50-
DESCRIPTION- NICOLAIDES ET AL., PROC NATL ACAD SCI USA, (1997), vol. 94, pages 13175 - 13180-
DESCRIPTION- ONDERDONK ET AL., REV INFECT DIS., (1979), vol. 1, no. 2, pages 291 - 301-
DESCRIPTION- ONDERDONK ET AL., REV INFECT DIS., (1990), vol. 12, no. 2, pages 169 - 77-
DESCRIPTION- ORNITZ ET AL., COLD SPRING HARBOR SYMP. QUANT. BIOL, (1986), vol. 50, pages 399 - 409-
DESCRIPTION- OTTOLINI ET AL., J INFECT DIS, (2002), vol. 186, no. 12, pages 1713 - 1717-
DESCRIPTION- PALLADINO ET AL., CANCER RES., (1987), vol. 47, pages 5074 - 5079-
DESCRIPTION- PARMLEY; SMITH, GENE, (1988), vol. 73, pages 305 - 318-
DESCRIPTION- PATH ET AL., AM J RESP & CRITICAL CARE MED, (2002), vol. 166, no. 6, pages 818 - 826-
DESCRIPTION- PHILLIPS ET AL., J PSYCHOPHARMACOL., (2000), vol. 14, no. 3, pages 244 - 50-
DESCRIPTION- PIAZZA, CANCER RESEARCH, (1995), vol. 55, page 3110 16-
DESCRIPTION- PINKERT ET AL., GENES AND DEVEL., (1987), vol. 1, pages 268 - 276-
DESCRIPTION- PLETNIKOV, FRONT BIOSCI, (2002), vol. 7, pages D593 - 607-
DESCRIPTION- POLLOCK ET AL., NAT GENET., (1995), vol. 9, no. 2, pages 202 - 9-
DESCRIPTION- PRELLNER ET AL., MICROB DRUG RESIST., (1999), vol. 5, no. 1, pages 73 - 82-
DESCRIPTION- QUIMBY; NGUYEN, CRIT REV MICROBIOL, (1985), vol. 12, no. 1, pages 1 - 44-
DESCRIPTION- RANGER; PEPPAS, J. MACROMOL. SCI. REV. MACROMOL. CHEM., (1983), vol. 23, page 61-
DESCRIPTION- READHEAD ET AL., CELL, (1987), vol. 48, pages 703 - 712-
DESCRIPTION- RIDGWAY ET AL., LAB ANIM SCI., (1986), vol. 36, no. 5, pages 481 - 5-
DESCRIPTION- RIVERA ET AL., J IMMUNO, (2002), vol. 168, no. 7, pages 3419 - 3427-
DESCRIPTION- SAIF ET AL., ARCH VIROL, (1996), vol. 12, pages 153 - 61-
DESCRIPTION- SALKOWSKI; BALISH, INFECT IMMUN., (1990), vol. 58, no. 10, pages 3300 - 6-
DESCRIPTION- SANI, NATURE, (1985), vol. 314, pages 283 - 286-
DESCRIPTION- SAUDEK ET AL., N. ENGL. J. MOD., (1989), vol. 321, page 574-
DESCRIPTION- SAUERMANN, CURR MOL MED, (2001), vol. 1, no. 4, pages 515 - 22-
DESCRIPTION- SAWADA ET AL., J. EXP. MED., (1998), vol. 187, pages 1439 - 1449-
DESCRIPTION- SCHEIBENBOGEN ET AL., INT. J. CANCER, (1997), vol. 71, pages 932 - 936-
DESCRIPTION- SCHELD, J ANTIMICROB CHEMOTHER., (1987), vol. 20, no. A, pages 71 - 85-
DESCRIPTION- SCHITO ET AL., CURR. HIV RES., (2006), vol. 4, pages 379 - 386-
DESCRIPTION- Scientific Tables, Geigy Pharmaceuticals, ARDLEY, (1970), page 537-
DESCRIPTION- SEFTON, CRC CRIT. REF. BIOMED. ENG., (1987), vol. 14, page 201-
DESCRIPTION- SHEPHARD ET AL., RES VET SCI, (2003), vol. 74, no. 2, pages 187 - 190-
DESCRIPTION- SHETTY; ANTIA, INDIAN J LEPR., (1996), vol. 68, no. 1, pages 95 - 104-
DESCRIPTION- SHIBUYA ET AL., MICROB PATHOG., (1999), vol. 27, no. 3, pages 123 - 31-
DESCRIPTION- SIDWELL ET AL., ANTIVIRAL RES., (2000), vol. 48, pages 1 - 16-
DESCRIPTION- SINGH ET AL., MYCOPATHOLOGIA, (1990), vol. 112, no. 3, pages 127 - 37-
DESCRIPTION- SMITH, CIBA FOUND SYMP., (1976), pages 45 - 72-
DESCRIPTION- STOTLAND ET AL., PEDIATR PULMONOL., (2000), vol. 30, no. 5, pages 413 - 24-
DESCRIPTION- SUGIYAMA ET AL., J GASTROENTEROL, (2002), vol. 37, no. 13, pages 6 - 9-
DESCRIPTION- SWIFT ET AL., CELL, (1984), vol. 38, pages 639 - 646-
DESCRIPTION- TAYLOR-ROBINSON, INFECTION, (1976), vol. 4, no. 1, pages 4 - 8-
DESCRIPTION- TEMANN ET AL., J EXP MED, (1998), vol. 188, no. 7, pages 1307 - 1320-
DESCRIPTION- TESCIUBA ET AL., J. IMMUNOL., (2001), vol. 167, pages 1996 - 2003-
DESCRIPTION- TIOLLAIS ET AL., NATURE, (1985), vol. 317, pages 489 - 495-
DESCRIPTION- TOMKINSON ET AL., J. IMMUNOL., (2001), vol. 166, pages 5792 - 5800-
DESCRIPTION- TREAT ET AL., Liposomes in the Therapy of Infectious Disease and Bacterial infection, LISS, (1989), pages 353 - 365-
DESCRIPTION- UCHIDA ET AL., JPN J ANTIBIOT., (1994), vol. 47, no. 10, pages 1407 - 12-
DESCRIPTION- "Useful proteins from recombinant bacteria", SCIENTIFIC AMERICAN, (1980), vol. 242, pages 74 - 94-
DESCRIPTION- VASSALLO ET AL., AM J RESPIR CELL MOL BIOL, (2001), vol. 25, no. 2, pages 203 - 211-
DESCRIPTION- VIERLING, BEST PRACT RES CLIN GASTROENTEROL, (2001), vol. 15, no. 4, pages 591 - 610-
DESCRIPTION- VILLA-KAMAROFF ET AL., PROC. NATL. ACAD. SCI. U.S.A., (1978), vol. 75, pages 3727 - 3731-
DESCRIPTION- VRIESENDORP, J INFECT DIS., (1997), vol. 176, no. 2, pages 164 - 8-
DESCRIPTION- WAGNER ET AL., PROC. NATL. ACAD. SCI. U.S.A., (1981), vol. 78, pages 1441 - 1445-
DESCRIPTION- WANG, CURR TOP MICROBIOL IMMUNOL., (2001), vol. 258, pages 201 - 19-
DESCRIPTION- WANG ET AL., INT J PANCREATOL, (2001), vol. 29, no. 1, pages 37 - 46-
DESCRIPTION- WHITE ET AL., BRAIN PATHOL, (2001), vol. 11, no. 4, pages 475 - 9-
DESCRIPTION- WICHER; WICHER, CRIT REV MICROBIOL., (1989), vol. 16, no. 3, pages 181 - 234-
DESCRIPTION- WILDER ET AL., AM J RESPIR CELL MOL BIOL, (2002), vol. 26, no. 3, pages 304 - 314-
DESCRIPTION- WILLIAMSET, J INFECT DIS., (1988), vol. 178, no. 4, pages 1217 - 21-
DESCRIPTION- WINTER C. A. ET AL., "Carrageenan Induced Edema in Hind Paw of the Rat as an Assay for Anti-inflammatory Drugs", PROC. SOC. EXP. BIOL MED., (1962), vol. 111, pages 544 - 547-
DESCRIPTION- WU ET AL., GASTROENTEROLOGY, (2005), vol. 128, pages 1416 - 1423-
DESCRIPTION- YAMAGATA ET AL., J CLIN MICROBIOL., (2000), vol. 38, no. 9, page 32606-
DESCRIPTION- YAMAMOTO ET AL., CELL, (1980), vol. 22, pages 787 - 797-
DESCRIPTION- YONEZAWA ET AL., J INFECT CHEMOTHER, (2000), vol. 6, no. 3, pages 155 - 161-
DESCRIPTION- YOSHIDA, KANSENSHOGAKU ZASSHI, (199806), vol. 72, no. 6, pages 621 - 30-
DESCRIPTION- ZHANG; ROTH, IN VIVO, (1994), vol. 8, no. 5, pages 755 - 6-
DESCRIPTION- ZHU ET AL., ANTIMICROBIAL AGENTS AND CHEMOTHER., (2006), vol. 50, pages 3260 - 3268-
EXAMINATION- Bamford ET AL, "The 5' untranslated region, signal peptide, and the coding sequence of the carboxyl terminus of IL-15 participate in its multifaceted translational control.", The Journal of Immunology, (19980501), vol. 160, no. 9, ISSN 0022-1767, pages 4418 - 4426, XP055054209-
EXAMINATION- ONU A ET AL, "Regulation of IL-15 secretion via the leader peptide of two IL-15 isoforms", THE JOURNAL OF IMMUNOLOGY, THE AMERICAN ASSOCIATION OF IMMUNOLOGISTS, US, (19970101), vol. 158, no. 1, ISSN 0022-1767, pages 255 - 262, XP002449794-
EXAMINATION- Yutaka Tagaya ET AL, "IL-15: A Pleiotropic Cytokine with Diverse Receptor/Signaling Pathways Whose Expression Is Controlled at Multiple Levels", IMMUNITY., US, (19960401), vol. 4, no. 4, doi:10.1016/S1074-7613(00)80246-0, ISSN 1074-7613, pages 329 - 336, XP055373155
EXAMINATION- T. A. Waldmann ET AL, "THE MULTIFACETED REGULATION OF INTERLEUKIN-15 EXPRESSION AND THE ROLE OF THIS CYTOKINE IN NK CELL DIFFERENTIATION AND HOST RESPONSE TO INTRACELLULAR PATHOGENS", ANNUAL REVIEW OF IMMUNOLOGY., US, (19990401), vol. 17, no. 1, doi:10.1146/annurev.immunol.17.1.19, ISSN 0732-0582, pages 19 - 49, XP055373158
OPPOSITION- C. BERGAMASCHI et al., "Intracellular Interaction of Interleukin-15 30 November with Its Receptor during Production Leads to Mutual Stabilization 2007 and Increased Bioactivity", JOURNAL OF BIOLOGICAL CHEMISTRY, (20080215), vol. 283, no. 7, pages 4189 - 4199, XP055622325-
OPPOSITION- "erleukin-15 receptor subunit alpha isoform 1 precursor (Homo sapiens)", Nucleotide, (20190512), Database accession no. NP_002180, XP055622331-
OPPOSITION- "Homo sapiens interleukin 15 (IL15), transcript variant 1, mRNA", Nucleotide, (20110123), Database accession no. NM_172174, URL: NCBI, XP055622328-
OPPOSITION- "Homo sapiens interleukin 15 precursor (IL-15) mRNA, completecds", Nucleotide, (19980123), Database accession no. AF031167.1, URL: NCBI, XP055622337-
OPPOSITION- "Human interleukin-15 receptor alpha chain precursor (IL15RA) mRNA, complete cds", Nucleotide, (19951219), Database accession no. U31628, URL: NCBI, XP055622340-
OPPOSITION- MORTIER E et al., "Natural , Proteolytic Release of a Soluble Form of 20 July 2004 Human IL -15 Receptor a-Chain That Behaves as a Specific, High Affinity IL -15 Antagonist", J. Immunol, (20040000), vol. 173, pages 1681 - 1688, XP002445753-
OPPOSITION- S. DUBOIS et al., "IL -15Ra Recycles and Presents IL-15 In Trans November to Neighbouring Cells", Immunity, (20020000), vol. 17, pages 537 - 547, XP055622333-
OPPOSITION- Y TAGAYA et al., "Generation of secretable and non-secretable December interleukin-15 isoforms through alternate usage of signal peptides", 1997 Proc. Natl. Acad. Sci. USA, (19971200), vol. 44, pages 14444 - 14449, XP055622334-
OPPOSITION- MATSUMOTO M. et al., "On-column refolding and characterization of September soluble human interleukin-15 receptor alpha-chain produced in 2003 Escherichia coli", Protein Expr Purif., (20030900), vol. 31, no. 1, doi:doi:10.1016/S1046-5928(03)00143-8, pages 64 - 71, XP002394328
OPPOSITION- D ANDERSON et al., "Functional Characterization of the Human December IL-15 Receptor a Chain and Close Linkage of IL 15RAand IL 2RA 1995 genes", J. Biol. Chem., (19951215), vol. 270, no. 50, pages 29862 - 29869, XP002056003
SEARCH- NORIKO SATO ET AL, "The IL-15/IL-15Ralpha on cell surfaces enables sustained IL-15 activity and contributes to the long survival of CD8 memory T cells", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES, NATIONAL ACADEMY OF SCIENCES, US, (20070109), vol. 104, no. 2, doi:10.1073/PNAS.0610115104, ISSN 0027-8424, pages 588 - 593, XP008128982 [A] 1-13 * the whole document *
SEARCH- C. BERGAMASCHI ET AL, "Intracellular Interaction of Interleukin-15 with Its Receptor during Production Leads to Mutual Stabilization and Increased Bioactivity", JOURNAL OF BIOLOGICAL CHEMISTRY, (20080215), vol. 283, no. 7, doi:10.1074/jbc.M705725200, ISSN 0021-9258, pages 4189 - 4199, XP055108535 [XP] 1-13 * the whole document *

Download Citation Report

Get a free citation report including examiner, opposition, and international search citations.

Get Citation Report

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents